Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer

British Journal of Cancer

Volumn 83, Issue 11, 2000, Pages 1425-1431

  Chin, K F ^a   Greenman, J ^a   Gardiner, E ^a   Kumar, H ^a   Topping, K ^a   Monson, J ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Colorectal cancer; Tumour marker; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033665761     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1508     Document Type: Article

References (26)

1. Clinical perspective of human colorectal cancer metastasis
2. Prognosis of node-positive colon cancer
3. Prognostic factors in colorectal cancer
4. Angiogenesis and metastasis
5. What is the evidence that tumours are angiogenesis dependent?
6. Angiogenesis and breast cancer
7. Angiogenesis
8. Prognostic factors of rectum carcinoma - Experience of the German multicentre study of SGCRC
9. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
10. Predictive value of vascular endothelial growth factor (VEGF) in metastases and prognosis of human colorectal cancer
11. Utilisation of serum VEGF to predict curative colorectal cancer resections
12. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer
13. Maximally selected chi square statistics
14. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
15. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
16. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum
17. The natural history of carcinoma of the colon and rectum
18. Recurrent colorectal carcinoma: Detection, treatment, and other consideration
19. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
20. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
21. High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer
22. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer
23. Clinicopathological assessment and staging of colorectal cancer
24. Concentrations of vascular endothelial growth factor in sera of normal control and cancer patients
25. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer